Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

EPIRUBICIN HYDROCHLORIDE

EPIRUBICIN HYDROCHLORIDE

Standard Dose
200MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview EPIRUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 050807 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient EPIRUBICIN HYDROCHLORIDE Form and strength POWDER;INTRAVENOUS - 200MG/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2013-06-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview EPIRUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 050807 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPIRUBICIN HYDROCHLORIDE Form and strength POWDER;INTRAVENOUS - 200MG/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2013-06-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.